Last Trade 3.4000
Bid 3.3600
Ask 3.4000
Open 3.4800
High 3.4800
Low 3.3700
Previous Close 3.5000
52-Week High 6.2500
52-Week Low
0.5999
Volume 7,663
Avg. Volume (90 Days) 134,489
Primary Exchange NASDAQ-NMS

Detailed Quote

CompareChart Options
Compare and Chart Options tabs. Compare tab selected.
 
S&P 500
DJIA
NASDAQ
Industry
Chart
 

News & Events

Log in for more news
  • Show article details.

    pSivida Corp Announces Second Quarter 2010 Financial Results Release Date and Conference Call Information

    Business Wire – 08:00:00 AM ET 02/04/2010

    pSivida Corp. (PSDV), a leading drug delivery company, today announced that its financial results for the second quarter of fiscal year 2010 will be released after market close on Thursday, February 11, 2010, followed the same day by a conference call and live webcast to discuss those results and its business scheduled for 4:30 p.m. ET.

  • Show article details.

    pSivida CEO To Discuss Ocular Drug Delivery in Diabetic Retinopathy At 6th Annual Diabetes Conference January 22 in London

    Business Wire – 10:00:00 AM ET 01/20/2010

    pSivida Corp. (PSDV), a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Dia...

  • Show article details.

    Drug stocks sluggish; Achillion, pSivida rally

    MarketWatch – 10:51:00 AM ET 12/23/2009

    Drug stocks managed narrow gains Wednesday afternoon, but a pair of small-cap biotech firms -- Achillion and pSivida -- rallied. The NYSE Arca Pharmaceutical Index and the NYSE Arca Biotechnology Index were both up fractionally to stand at 311.49 and 935.98, respectively.

  • Show article details.

    pSivida's eye drug shows promise in study, shares surge

    Reuters – 08:36:00 AM ET 12/23/2009

    * Study meets goal in intent-to-treat population. * Drug fails in a study on a different group. * Says partner Alimera Sciences to file NDA in Q2 2010 * Shares up as much as 72 pct. By Krishnakali Sengupta.

  • Show article details.

    Form 8-K pSivida Corp. For: Dec 23

    SEC filings - 10K Wizard – 07:39:00 AM ET 12/23/2009

    http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6664665. Filed on: December 23, 2009.

Events

  • Feb
    11

    PSDV to announce Q2 earnings After Market (Confirmed)

  • Feb
    11

    PSDV Earnings Conference Call at 4:30 PM Listen

More News & Events

Company Profile

Log in for more information

Sector

Health Care

pSivida Corp., together with its subsidiaries, develops drug delivery products in the healthcare sector. It develops products utilizing its proprietary technologies, including Durasert, BioSilicon, CODRUG, and Medidur.

Environmental, Social & Governance Summary (ESG)

  More information

ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities. Log in for more information

About Environmental, Social & Governance Summary (ESG)

KLD ESG Composite Rating

The KLD ESG Composite Rating is a measure of how well a company manages ESG risks and addresses ESG opportunities. If a company is performing adequately on this measure, it receives a Yellow rating. If it is more effective, it receives a Green rating. If the company is not managing ESG risks and opportunities effectively, it receives a Red rating. The KLD Composite Rating is provided for the largest 3,000 U.S companies by market capitalization.

About KLD Research & Analytics, Inc.

KLD Research & Analytics, Inc. is an independent investment research firm founded in 1988. They provide assessment tools for professionals and individuals who would like to integrate environmental, social and governance factors (ESG) into their investment decisions. KLD has over 20 years of ESG research experience and has become an industry leader in screening for environmental, social and governance factors. They are one of the leading authorities on social research and indexes.

More About KLD Research & Analytics, Inc.

KLD Vice Alert

A KLD Vice Alert is triggered when a company derives at least 15% of its revenue from adult entertainment, alcohol, gambling, and/or tobacco. KLD Research ensures the accuracy of company information with frequent updates using data from public documents, non-governmental agencies, government agencies, press searches, trade journals, industry and regional publications, and direct contact with companies. Rigorous internal quality assurance and editing processes ensure consistent coverage across all publicly traded companies and issues.

About KLD Research & Analytics, Inc.

KLD Research & Analytics, Inc. is an independent investment research firm founded in 1988. They provide assessment tools for professionals and individuals who would like to integrate environmental, social and governance factors (ESG) into their investment decisions. KLD has over 20 years of ESG research experience and has become an industry leader in screening for environmental, social and governance factors. They are one of the leading authorities on social research and indexes.

More About KLD Research & Analytics, Inc.

Audit Integrity Accounting and Governance Risk (AGR®) Score & Rating

The Audit Integrity Accounting and Governance Risk (AGR®) Score & Rating is widely recognized as an indicator of the confidence level surrounding a company's management and reported financials.

Scores range from 0 to 100, and correspond to a risk classification for each company ranging from "Very Aggressive" to "Conservative." The AGR Score is a percentile ranking among the approximately 8.000 companies rated by Audit Integrity. Through continued back-testing, Audit Integrity has demonstrated a strong correlation between its quarterly AGR® Score and the likelihood of adverse events, including securities class action litigation, financial restatements, regulatory enforcement actions, and stock price declines. Thus, a company's AGR® Score can help investors looking to manage risk or enhance investment performance. Audit Integrity forensically analyzes the financial reporting and governance practices of over 8,000 North American-based publicly traded companies.

About Audit Integrity, Inc.

Audit Integrity is an independent risk research firm which provides a statistically modeled assessment of corporate integrity. Founded in 2002 in direct response to the growing number of scandals, lawsuits and investor losses resulting from fraudulent corporate behavior, the firm identifies potential high-risk company accounting and governance activity, which in turn has been historically correlated to stock price declines, securities class-action litigation, and material financial restatements. The product of Audit Integrity's analysis is a unique risk measure - the AGR® Score which can be used by investors as a way to more effectively manage corporate risk.

More About Audit Integrity, Inc.

Full Time Employees: 22

Analyst Recommendations & Reports

Analyst Recommendations

Log in to see select Analyst Recommendations for PSDV.

Reports

All Analyst Recommendations & Reports All Analyst Recommendations & Reports

Compare

PSDVIndustry AveragePercentile
in Industry
Market Capitalization$64.03M$1.15B43rd
Beta2.650.9896th
EPS (TTM)
$-0.20$1.7738th
Current Consensus EPS Estimate------
EPS Growth
(TTM vs. Prior TTM)
-95.16%+29.29%10th
P/E Ratio (TTM)
-17.5027.4813rd
Dividend Yield (TTM)0.00%1.94%--
Total Revenue (TTM)
$12.74M$3.70B38th
Revenue Growth
(TTM vs Prior TTM)
+106.17%+10.91%97th
Shares Outstanding18,294,00018,294,00027th
Shares Short*
108,592----
% Owned by
Institutions
9.59%86.13%32nd

* Short Interest data provided by NASDAQ, NYSE, or AMEX and is updated periodically and on a monthly basis (depending on the listing exchange).